Unfractionated versus low-molecular-weight heparin for primary angioplasty-More data suggesting to go low.

Subjects

Subjects :

Anticoagulants adverse effects
Enoxaparin adverse effects
Evidence-Based Medicine
Hemorrhage chemically induced
Hemorrhage prevention & control
Heparin adverse effects
Hospital Mortality
Humans
Myocardial Infarction mortality
Platelet Aggregation Inhibitors therapeutic use
Risk Assessment
Risk Factors
Secondary Prevention
Time Factors
Treatment Outcome
Angioplasty, Balloon, Coronary adverse effects
Angioplasty, Balloon, Coronary mortality
Anticoagulants therapeutic use
Enoxaparin therapeutic use
Heparin therapeutic use
Myocardial Infarction therapy

Details

Language :

English

ISSN :

1522-726X

Volume :

77

Issue :

2

Database :

MEDLINE

Journal :

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions

Publication Type :

Editorial & Opinion

Accession number :

21290553

Full Text :

https://doi.org/10.1002/ccd.22953